Shanghai Sanyou Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	510.43	451.7	456.91	647.8	592.95	390.35
Other Revenue	1.9	1.9	3.48	1.35	0.41	0.08
Revenue	512.33	453.6	460.39	649.15	593.36	390.43
Revenue Growth (YoY)	17.99%	-1.48%	-29.08%	9.40%	51.98%	10.19%
Cost of Revenue	145.62	145.95	103.81	71.39	63.61	40.27
Gross Profit	366.71	307.65	356.58	577.77	529.75	350.17
Selling, General & Admin	234.35	211.71	193.48	333.64	323.13	205.42
Research & Development	76.01	84.29	65.22	60.38	56.55	33.92
Other Operating Expenses	0.73	4.46	5.07	7.68	6.49	4
Operating Expenses	314.94	301.5	255	404.49	389.04	245.83
Operating Income	51.77	6.14	101.58	173.28	140.71	104.33
Interest Expense	-0.99	-1.17	-0.27	-0.2	-0.16	-
Interest & Investment Income	10.05	13.6	16.25	14.53	34.3	23.66
Currency Exchange Gain (Loss)	-0.74	-0.74	0.32	0.1	-0.17	-0.33
Other Non Operating Income (Expenses)	7.81	-1.43	-0.31	-0.2	0.19	1.67
EBT Excluding Unusual Items	67.9	16.39	117.58	187.51	174.87	129.33
Impairment of Goodwill	-0.07	-0.07	-	-	-	-
Gain (Loss) on Sale of Investments	2.23	4.16	-6.89	36.32	27.33	-
Gain (Loss) on Sale of Assets	6.38	6.42	-0.05	-0.06	-0.19	-
Asset Writedown	-8.4	-10.13	-	-	-	-
Other Unusual Items	5.13	5.13	24.22	15.78	15.33	7.61
Pretax Income	73.16	21.9	134.87	239.54	217.33	136.95
Income Tax Expense	15.12	9.79	21.23	35.99	22.18	18.39
Earnings From Continuing Operations	58.04	12.11	113.64	203.56	195.15	118.56
Minority Interest in Earnings	6.84	-0.64	-18.06	-12.74	-8.78	-
Net Income	64.88	11.47	95.58	190.82	186.37	118.56
Net Income to Common	64.88	11.47	95.58	190.82	186.37	118.56
Net Income Growth	71.34%	-88.00%	-49.91%	2.39%	57.20%	21.20%
Shares Outstanding (Basic)	305	275	302	297	296	273
Shares Outstanding (Diluted)	305	275	302	297	296	273
Shares Change (YoY)	3.50%	-8.87%	1.49%	0.33%	8.47%	23.13%
EPS (Basic)	0.21	0.04	0.32	0.64	0.63	0.43
EPS (Diluted)	0.21	0.04	0.32	0.64	0.63	0.43
EPS Growth	65.56%	-86.83%	-50.65%	2.05%	44.92%	-1.57%
Free Cash Flow	-2.81	-26.47	241.5	17.78	53.26	47.07
Free Cash Flow Per Share	-0.01	-0.10	0.80	0.06	0.18	0.17
Dividend Per Share	0.004	0.004	0.065	0.064	0.125	0.120
Dividend Growth	-94.62%	-94.62%	0.93%	-48.64%	4.67%	-
Gross Margin	71.58%	67.82%	77.45%	89.00%	89.28%	89.69%
Operating Margin	10.11%	1.35%	22.06%	26.69%	23.71%	26.72%
Profit Margin	12.66%	2.53%	20.76%	29.39%	31.41%	30.37%
Free Cash Flow Margin	-0.55%	-5.84%	52.45%	2.74%	8.98%	12.06%
EBITDA	85.38	36.41	127.39	188.63	153.9	114.37
EBITDA Margin	16.66%	8.03%	27.67%	29.06%	25.94%	29.29%
D&A For EBITDA	33.61	30.27	25.81	15.35	13.19	10.04
EBIT	51.77	6.14	101.58	173.28	140.71	104.33
EBIT Margin	10.11%	1.35%	22.06%	26.69%	23.71%	26.72%
Effective Tax Rate	20.67%	44.70%	15.74%	15.02%	10.21%	13.43%
Revenue as Reported	512.33	453.6	460.39	649.15	593.36	390.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.